Radiation products maker Mirion beats Q3 revenue estimates, reaffirms 2025 revenue forecast

Reuters
2025/10/29
Radiation products maker <a href="https://laohu8.com/S/MIR">Mirion</a> beats Q3 revenue estimates, reaffirms 2025 revenue forecast

Overview

  • Mirion Q3 revenue rises 7.9% to $223.1 mln, beating analyst expectations

  • GAAP net income for Q3 was $3.1 mln, compared to a loss last year

  • Adjusted EBITDA for Q3 increases 14.7% to $52.4 mln

Outlook

  • Mirion raises lower end of adjusted Free Cash Flow guidance to $100 mln - $115 mln

  • Company reaffirms 2025 guidance for revenue growth, adjusted EBITDA, and adjusted EPS

  • Mirion's 2025 guidance excludes impact from Paragon acquisition

Result Drivers

  • NUCLEAR POWER MOMENTUM - Co cites continued momentum in nuclear power end-market as key driver of Q3 results

  • ACQUISITIONS - Paragon and Certrec acquisitions expected to boost nuclear revenue to 45% of total revenue

  • NEW ORDERS - Awarded $10 mln modular reactor order and $55 mln Asia order as part of $350 mln pipeline

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$223.10 mln

$222.15 mln (7 Analysts)

Q3 Net Income

$3.10 mln

Q3 EBIT

$7.40 mln

Q3 Gross Profit

$104.50 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

  • Wall Street's median 12-month price target for Mirion Technologies Inc is $26.00, about 5.6% above its October 27 closing price of $24.54

  • The stock recently traded at 44 times the next 12-month earnings vs. a P/E of 41 three months ago

Press Release: ID:nBw7Srl0ma

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10